IXICO (LON:IXI) Shares Up 16.9% – Here’s Why

IXICO plc (LON:IXI) rose 16.9% on Tuesday. The company traded as high as GBX 12.50 and last traded at GBX 11.98. Approximately 449,418 shares traded hands during mid-day trading, an increase of 314% from the average daily volume of 108,557 shares. The stock had previously closed at GBX 10.25.

IXICO Stock Performance

The company has a market cap of £26.23 million, a price-to-earnings ratio of -6.14, a P/E/G ratio of -0.38 and a beta of 0.11. The company has a current ratio of 2.83, a quick ratio of 4.90 and a debt-to-equity ratio of 5.22. The stock’s 50 day moving average price is GBX 7.89 and its 200 day moving average price is GBX 8.28.

IXICO Company Profile

IXICO is a global leader in neuroscience imaging and biomarker analytics, using its proprietary AI-driven platform to help advance the treatment of neurological disorders and reduce the uncertainties associated with drug discovery, development and monitoring.

By unlocking valuable insights into drug safety and efficacy, IXICO has built a global reputation and 20-year track record as an end-to-end Imaging Contract Research Organisation (iCRO) managing and analysing neurological clinical trials.